BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Field Safety Notice for MYO2 (Tina-quant Myoglobin Gen.2) by Roche Diagnostics GmbH

Product group In-vitro diagnostics - immunological products
Reference 22901/21

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Urgent Field Safety Notice for MYO2 (Tina-quant Myoglobin Gen.2) by Roche Diagnostics GmbH , Download_VeroeffentlichtAm_EN PDF, 748KB, File does not meet accessibility standards